Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Emergent BioSolutions Inc. | SVP, R&D, CMO | Common Stock | 29.5K | $266K | $9.01 | Dec 15, 2024 | Direct |
Emergent BioSolutions Inc. | SVP, R&D, CMO | Employee Stock Option (Right to buy) | 40.5K | Dec 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EBS | Emergent BioSolutions Inc. | Dec 15, 2024 | 2 | $0 | 4 | Dec 17, 2024 | SVP, R&D, CMO |
EBS | Emergent BioSolutions Inc. | Nov 18, 2024 | 0 | $0 | 3 | Nov 21, 2024 | SVP, R&D, CMO |